Abstract
Struma ovarii, tümör dokusunun yarısından fazlasını tiroid dokusunun oluşturduğu nadir görülen bir over tümörüdür. Çalışmalarda hastalığın %0.5-5 oranında malign transformasyonu saptanmıştır. Nadir görülen bir hastalık olmasından dolayı tanı ve tedavisinde kesin bir görüş birliği yoktur ve genel kabul edilen yaklaşım malign struma ovarii vakalarının tiroid kanseri gibi tedavi ve takip edilmesidir. Bu olgu sunumunda struma ovarii zemininde gelişen bir papiller mikrokarsinom vakasının tedavisi ve 1 yıllık takibini sunmayı amaçladık
References
- Devaney K, Snyder R, Norris HJ, Tavasolli FA. Proliferative and histologically malignant struma ovarii: a clinicopatho- logic study of 54 cases. Int J Gynecol Pathol 1993;12:333-43.
- DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I-131 therapy. Gynecol Oncol 2003;89:543-8.
- Dardik RB, Dardik M, Westra W, Montz FJ. Malignant stru- ma ovarii: two case reports and a review of the literature. Gynecol Oncol 1999;73:447-51.
- Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ. Ma- lignant struma ovarii. Gynecol Oncol 1989;32:224-7.
- Makani S, Kim W, Gaba AR. Struma ovarii with a focus of papillary thyroid cancer: a case report and review of the li- terature. Gynecol Oncol 2004;94:835-9.
- Wagner CP, Hicks BN, Nakamura KM. Incidental scin- tigraphic detection of struma ovarii following total thy- roidectomy for papillary thyroid cancer. Radiol Case Rep 2015;6:478.
- Rose PG, Arafah B, Abdul-Karim FW. Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 1998;70:425-7.
- Yoo S-C, Chang Ki-Hong, Lyu Mi-Ok ve ark. Clinical cha- racteristics of struma ovarii. J Gynecol Oncol 2008;19:135- 8.
- Marcy PY, Thariat J, Benisvy D, Azuar P. Lethal, malignant, metastatic struma ovarii. Thyroid 2010;10:1037-40.
- Yassa L, Sadow P, Marqusee E. Malignant struma ovarii. Nat Clin Pract Endocrinol Metab 2008;4:469-72.
- Casey MB, Lohse CM, Lloyd RV. Distinction between pa- pillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galec- tin-3, and HBME-1. Endocr Pathol 2003;14:55-60.
- Hatami M, Breining D, Owers RL, Del Priore G, Goldberg GL. Malignant struma ovarii--a case report and review of the literature. Gynecol Obstet Invest 2008;65:104-7.
- Gunasekaran S, Kopecka E, Maung KH, England RJ. Struma ovarii and the thyroid surgeon. J Laryngol Otol 2012;126:858-60.
- Meringolo D, Bianchi D, Capula C, Costante G. Papil- lary thyroid microcarcinoma in struma ovarii. Endocrine 2012;41:164-5.
Abstract
Struma ovarii is an uncommon ovarian neoplasm that more than half of itself is made up of thyroid tissue. In clinical trials about the disease, malign transformation has been detected at the rate of 0.5-5 percent. Because of the disease's rareness, there is no absolute agreement about diagnosis and treatment of the disease and general approach is that malign struma ovarii case is treated and followed up just like done in thyroid cancers. In this case report, it is aimed to represent the treatment and 1-year follow up of papillary microcarcinoma case which evolves with struma ovarii
References
- Devaney K, Snyder R, Norris HJ, Tavasolli FA. Proliferative and histologically malignant struma ovarii: a clinicopatho- logic study of 54 cases. Int J Gynecol Pathol 1993;12:333-43.
- DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I-131 therapy. Gynecol Oncol 2003;89:543-8.
- Dardik RB, Dardik M, Westra W, Montz FJ. Malignant stru- ma ovarii: two case reports and a review of the literature. Gynecol Oncol 1999;73:447-51.
- Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ. Ma- lignant struma ovarii. Gynecol Oncol 1989;32:224-7.
- Makani S, Kim W, Gaba AR. Struma ovarii with a focus of papillary thyroid cancer: a case report and review of the li- terature. Gynecol Oncol 2004;94:835-9.
- Wagner CP, Hicks BN, Nakamura KM. Incidental scin- tigraphic detection of struma ovarii following total thy- roidectomy for papillary thyroid cancer. Radiol Case Rep 2015;6:478.
- Rose PG, Arafah B, Abdul-Karim FW. Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 1998;70:425-7.
- Yoo S-C, Chang Ki-Hong, Lyu Mi-Ok ve ark. Clinical cha- racteristics of struma ovarii. J Gynecol Oncol 2008;19:135- 8.
- Marcy PY, Thariat J, Benisvy D, Azuar P. Lethal, malignant, metastatic struma ovarii. Thyroid 2010;10:1037-40.
- Yassa L, Sadow P, Marqusee E. Malignant struma ovarii. Nat Clin Pract Endocrinol Metab 2008;4:469-72.
- Casey MB, Lohse CM, Lloyd RV. Distinction between pa- pillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galec- tin-3, and HBME-1. Endocr Pathol 2003;14:55-60.
- Hatami M, Breining D, Owers RL, Del Priore G, Goldberg GL. Malignant struma ovarii--a case report and review of the literature. Gynecol Obstet Invest 2008;65:104-7.
- Gunasekaran S, Kopecka E, Maung KH, England RJ. Struma ovarii and the thyroid surgeon. J Laryngol Otol 2012;126:858-60.
- Meringolo D, Bianchi D, Capula C, Costante G. Papil- lary thyroid microcarcinoma in struma ovarii. Endocrine 2012;41:164-5.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | March 1, 2017 |
| Published in Issue | Year 2017 Volume: 27 Issue: 1 |
The Journal of General Medicine is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC).